KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Current Assets (2018 - 2025)

Historic Current Assets for Aurinia Pharmaceuticals (AUPH) over the last 10 years, with Q3 2025 value amounting to $438.7 million.

  • Aurinia Pharmaceuticals' Current Assets fell 39.1% to $438.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $438.7 million, marking a year-over-year decrease of 39.1%. This contributed to the annual value of $446.6 million for FY2024, which is 513.09% up from last year.
  • According to the latest figures from Q3 2025, Aurinia Pharmaceuticals' Current Assets is $438.7 million, which was down 39.1% from $409.0 million recorded in Q2 2025.
  • In the past 5 years, Aurinia Pharmaceuticals' Current Assets ranged from a high of $513.3 million in Q4 2021 and a low of $329.2 million during Q3 2021
  • Moreover, its 5-year median value for Current Assets was $424.8 million (2023), whereas its average is $423.0 million.
  • Per our database at Business Quant, Aurinia Pharmaceuticals' Current Assets crashed by 2002.26% in 2021 and then skyrocketed by 3963.41% in 2022.
  • Quarter analysis of 5 years shows Aurinia Pharmaceuticals' Current Assets stood at $513.3 million in 2021, then decreased by 13.79% to $442.5 million in 2022, then dropped by 4.01% to $424.8 million in 2023, then rose by 5.13% to $446.6 million in 2024, then fell by 1.76% to $438.7 million in 2025.
  • Its Current Assets stands at $438.7 million for Q3 2025, versus $409.0 million for Q2 2025 and $405.8 million for Q1 2025.